Medications

FDA OKs sale of 'Morning-after' pill without age limit

(HealthDay)—The so-called morning-after pill is about to go over-the-counter, with the U.S. Food and Drug Administration announcing Thursday that it has approved unrestricted sales of Plan B One-Step.

HIV & AIDS

Sexually transmitted HIV: Key mechanisms elucidated in men

Having suggested in 2011 that the urethra is a novel entry site for HIV, a team from the Institut Cochin (CNRS/Inserm/Université Paris Descartes, with the support of Anrs), has now confirmed this hypothesis and identified ...

Oncology & Cancer

Q+A: Should cervical cancer tests start later?

UK health authorities have recommended women start having pap smears later in life, suggesting women wait until they are at least 25 before having their first cervical cancer screening.

HIV & AIDS

Texas Biomed files patent for a novel HIV vaccine strategy

The Texas Biomedical Research Institute in San Antonio has applied for a patent for a genetically-engineered vaccine strategy to prevent HIV infection that targets the outer layers of body structures that are the first sites ...

page 13 from 18